ARS Pharmaceuticals Inc. logo

ARS Pharmaceuticals Inc.

SPRY | NASDAQ
Chart Builder DCF Calculator
$4.35
+$0.24 (+5.84%)
At close: Sep 21, 2026, 4:00 PM ET
$4.35
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$408.14M
Enterprise Value
$288.12M
Beta
0.88
Average Volume
1.94M
Shares Outstanding (Diluted)
99.31M
Shares Change YoY
0.97%
Institutional Ownership
94.77%
Exchange
NASDAQ
ISIN
US82835W1080

Price Performance

Price Change 1M
-19.4%
Price Change 3M
-57.7%
Price Change 6M
-44.9%
Price Change YTD
-62.1%
Price Change 1Y
-55.6%
Price Change 3Y
9.8%
Price Change 5Y
-58.9%
1M CAGR (ann.)
-25.9%
1Y CAGR (ann.)
-57.0%
5Y CAGR (ann.)
-26.7%
All-Time CAGR
-26.8%

Valuation

PE Ratio
-2.00
Forward PE
N/A
PEG Ratio
0.02
Forward PEG
0.03
PS Ratio
3.69
Forward PS
2.30
PB Ratio
34.52
P/FCF Ratio
-2.20
P/Adj. FCF Ratio
-1.90
P/OCF Ratio
-2.20
EV/Sales
2.46
EV/EBIT
-1.36
EV/EBITDA
-1.38
EV/FCF
-1.47
Earnings Yield
-50.1%
FCF Yield
-45.5%
Adj. FCF Yield
-52.8%

Financial Health

Net Cash
$143.85M
Total Debt
$0
Cash & Short-Term Investments
$143.85M
Total Assets
$249.5M
Current Ratio
3.48
Quick Ratio
3.28
Debt / Equity Ratio
13.72
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
-43.96
Altman Z-Score
-2.92
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
73.9%
Operating Profit Margin
-185.0%
EBITDA Margin
-177.0%
Net Profit Margin
-184.2%
FCF Margin
-168.1%
Adj. FCF Margin
-194.9%
SBC / Revenue
26.7%
SBC Impact (per share)
-15.9%

Returns

Return on Assets
-86.3%
Return on Equity
-256.7%
Return on Invested Capital
-114.6%
Return on Capital Employed
-114.7%
Return on Tangible Assets
-91.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
711.3%
Revenue CAGR 5Y
94.3%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-81.4%
EPS CAGR 5Y
-40.2%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-77.7%
FCF CAGR 5Y
-34.7%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
10
EPS Growth Next 3Y
40.4%
Revenue Growth Next 3Y
48.1%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$20
Price Target Upside
359.8%

Cash Flow

Operating Cash Flow
$-196.41M
Free Cash Flow
$-196.6M
Adj. Free Cash Flow
$-227.85M
FCF Per Share
-$1.98
OCF Per Share
-$1.98
OCF/S Ratio
-168.0%

Income Statement

Revenue
$116.93M
Gross Profit
$86.4M
Operating Income
$-216.27M
EBITDA
$-209.03M
Net Income
$-215.43M
EPS (Diluted)
-$2.18
Revenue / Employee
$599.63K
Profit / Employee
$-1.1M
Employees
195

© 2026 bestshares.com. All rights reserved.